| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 10/24/2006 | CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives |
| 10/24/2006 | CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 10/19/2006 | WO2006108709A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
| 10/19/2006 | WO2006085118A3 Dihydroimidazothiazole derivatives |
| 10/19/2006 | CA2604353A1 Sulfoximine-pyrimidine macrocycles and the salts thereof , a process for making them, and their pharmaceutical use against cancer |
| 10/18/2006 | EP1711505A2 Process for the preparation of thiazolopyrimidines |
| 10/18/2006 | EP1711499A2 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 10/18/2006 | CN1849336A Chimeric gabab receptor |
| 10/18/2006 | CN1849325A Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases |
| 10/18/2006 | CN1280275C Pyridione derivatives for tretment of atherosclerosis |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/17/2006 | US7122534 Aryl fused azapolycyclic compounds |
| 10/17/2006 | US7122081 Reducing particle size of organic pigments by milling the crude pigment in the presence of a water soluble styrene copolymer dispersant, optionally a defoamer, optionally an additive, and greater than about 10 wt. % water, and isolating the organic pigment |
| 10/12/2006 | WO2006107258A1 Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| 10/12/2006 | WO2006107257A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives |
| 10/12/2006 | WO2006106963A1 Triamine derivative |
| 10/12/2006 | WO2006106804A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/12/2006 | WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/12/2006 | WO2006066956A3 Sulfonamido-macrocycles as tie2 inhibitors |
| 10/12/2006 | WO2006065755A3 Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 10/12/2006 | US20060229302 Tricyclic indole derivatives and their use in the treatment of alzheimer's disease |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | CA2604016A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives |
| 10/12/2006 | CA2602228A1 Triamine derivative |
| 10/12/2006 | CA2602025A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/12/2006 | CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/11/2006 | EP1710246A1 Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 10/10/2006 | US7119088 A bi-heterocycle-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives; for therapy of dysmenorrhoea, anxiety disorder, asthma, atherosclerosis, cardiac failure, cardiovascular disease, cataract, central nervous system disease, motion sickness, Raynaud's disease, rheumatoid arthritis; chemical synthesis |
| 10/05/2006 | WO2006104226A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006103399A1 Hiv integrase inhibitors |
| 10/05/2006 | WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223844 Mitotic kinesin inhibitors |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | CA2585333A1 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | CN1277823C Novel benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115640 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
| 10/03/2006 | US7115622 Amido ether substituted imidazoquinolines |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 09/28/2006 | WO2006100520A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | CA2602395A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 09/27/2006 | EP1704154A1 Novel indeno [2,1a]indenes and isoindol [2,1-a]indoles |
| 09/27/2006 | CN1837218A N2,N4-disubstituted pyrazolo [4.5-e][1,2,4] thiadiazine derivatives and use thereof |
| 09/27/2006 | CN1837217A 4-substituted heterocyclo thiadiazine derivatives and process for preparing same |
| 09/27/2006 | CN1837216A Process for preparing 2,4-disubstituted heterocyclo [4,5-e][1,2,4] thiadiazine derivatives |
| 09/27/2006 | CN1837215A N1,N3-disubstituted thieno[3,2-e][2,1,3] thiadiazine-2,2,4-triones derivatives and use thereof |
| 09/26/2006 | US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
| 09/21/2006 | WO2006099379A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 09/21/2006 | WO2006098961A2 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 09/21/2006 | WO2006097691A1 Fused thiazole derivatives having affinity for the histamine h3 receptor |
| 09/21/2006 | WO2006081182A3 Antibacterial agents |
| 09/21/2006 | WO2006061373A3 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | CA2601644A1 Fused thiazole derivatives having affinity for the histamine h3 receptor |
| 09/21/2006 | CA2599899A1 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701962A2 Rifamycin analogs and uses thereof |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/20/2006 | CN1835956A Acylated and non-acylated imidazo [2,1-b]-1, 3, 4,-thiadiazole-2-sulfonamides, and uses thereof |
| 09/20/2006 | CN1835955A 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 09/20/2006 | CN1835948A 2-acylaminothiazole derivative or its salt |
| 09/20/2006 | CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/19/2006 | US7109340 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 09/19/2006 | US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/14/2006 | WO2006095360A1 Process for preparing substituted benzothiazinoindoles |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006094666A1 Heterobicyclic acrylamides |
| 09/14/2006 | WO2006040151A8 Subsituted hydroxyethylamine compounds for treating alzheimer’s disease |
| 09/14/2006 | WO2005112923A3 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/13/2006 | CN1832938A N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/13/2006 | CN1832740A Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1832739A Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1832738A Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1274678C New benzothiazine and benzothiadiazine compounds,its preparation process and pharmaceutical composition containing said compounds |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105524 2-(3,4,4-Trifluoro-but-3-enylsulfanyl)-thiazolo[5,4-b]pyridine; treating, controlling warm-blooded animals, fish and humans against infestation and infection by nematodes, helminths, arachnids and arthropod endo- and ectoparasites. |